Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Stem Cell Mobilization and Harvesting Failure in Case of Heavily Pretreated Patients

Stem Cell Mobilization and Harvesting Failure in Case of Heavily Pretreated Patients AbstractBackground: High-dose chemotherapy and autologous stem cell transplantation have become a standard curative treatment in various hematologic malignancies. Many factors can affect the success of mobilization and hematopoietic stem cell harvesting.Aim: The aim of this study was to analyze factors that lead to mobilization failure.Material and Methods: We conducted a retrospective study on 19 patients with failure of stem cell harvesting. All patients were administered high doses of GCS-F (filgrastim, 15 μg/kg/day) and 0.24 mg/kg of plerixafor on day +5 or +10 of harvesting.Results: The median age of the study population was 51 years (range 35–67) and 52.6% (n = 10) were males. The study group included 4 (21%) subjects with multiple myeloma, 6 (31.5%) with Hodgkin lymphoma, 8 cases (42.1%) with non-Hodgkin lymphoma and 1 patient with chronic lymphocytic leukemia. Each patient received 2.78 (range 1–5) lines of chemotherapy, administered in 11.57 (range 2 to over 20) cycles of treatment.Conclusion: In hematologic malignancies it is very important to collect stem cells in time, in order to reduce mobilization failure. As we have shown in our studied cases, multiple lines of polychemotherapy with or without radiotherapy lead to mobilization failure. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Interdisciplinary Medicine de Gruyter

Stem Cell Mobilization and Harvesting Failure in Case of Heavily Pretreated Patients

Download PDF
3 pages

Loading next page...
 
/lp/de-gruyter/stem-cell-mobilization-and-harvesting-failure-in-case-of-heavily-sfrm2DMdpr
Publisher
de Gruyter
Copyright
© 2017 Eszter Mild et al., published by De Gruyter Open
ISSN
2501-5974
eISSN
2501-8132
DOI
10.1515/jim-2017-0100
Publisher site
See Article on Publisher Site

Abstract

AbstractBackground: High-dose chemotherapy and autologous stem cell transplantation have become a standard curative treatment in various hematologic malignancies. Many factors can affect the success of mobilization and hematopoietic stem cell harvesting.Aim: The aim of this study was to analyze factors that lead to mobilization failure.Material and Methods: We conducted a retrospective study on 19 patients with failure of stem cell harvesting. All patients were administered high doses of GCS-F (filgrastim, 15 μg/kg/day) and 0.24 mg/kg of plerixafor on day +5 or +10 of harvesting.Results: The median age of the study population was 51 years (range 35–67) and 52.6% (n = 10) were males. The study group included 4 (21%) subjects with multiple myeloma, 6 (31.5%) with Hodgkin lymphoma, 8 cases (42.1%) with non-Hodgkin lymphoma and 1 patient with chronic lymphocytic leukemia. Each patient received 2.78 (range 1–5) lines of chemotherapy, administered in 11.57 (range 2 to over 20) cycles of treatment.Conclusion: In hematologic malignancies it is very important to collect stem cells in time, in order to reduce mobilization failure. As we have shown in our studied cases, multiple lines of polychemotherapy with or without radiotherapy lead to mobilization failure.

Journal

Journal of Interdisciplinary Medicine – de Gruyter

Published: Dec 1, 2017

References

  • CM stem cells for transplantation
    Verfaillie
  • Plerixafor and granulocyte - colony - stimulating factor in patients with lymphoma and multiple myeloma previously failing mobilization with CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization the Austrian experience on a
    Worel
  • AD Advances in mobilization for the optimization of autologous stem cell transplantation Lymphoma
    Vose
  • What is the optimum number of CD peripheral blood stem cells for an autologous transplant
    Jillella
  • To CA The biology and clinical uses of blood stem cells
    Haylock
  • Predictive factors for poor peripheral blood stem cell mobilization and peak CD cell count to guide pre - emptive or immediate rescue mobilization
    Sancho
  • To How treat patients who mobilize hematopoietic stem cells poorly
    Levesque
  • Peripheral blood stem cell versus bone marrow allotransplantation : does the source of hematopoietic stem cell matter
    Korbling